Browsing by Author Ribi, Karin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2016Adjuvant ovarian function suppression and cognitive function in women with breast cancerBoyle, Frances; Coates, Alan; Bellet, Meritxell; Budman, Daniel; et al, .; Francis, Prudence; Karlsson, Per; Phillips, Kelly-Anne; Puglisi, Fabio; Regan, Meredith; Ribi, Karin; Spazzapan, Simon; Zaman, Khalil; Northern Clinical School: Medicine; School of Public Health: Public HealthAdjuvant ovarian function suppression and cognitive function in women with breast cancer, British Journal of Cancer, vol.114, 9, 2016,pp 956-964
2013Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trialCoates, Alan; Crivellari, Diana; Dellapasqua, S; et al, Various; Gianni, Lorenzo; Gray, Kathryn P; Lang, Istvan; Pinotti, Graziella; Price, Karen N; Puglisi, Fabio; Ribi, Karin; Spazzapan, Simon; School of Public Health: Public HealthAdjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial, The Breast, vol.22, 2, 2013,pp 130-137
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2012Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?Butow, Phyllis; Juraskova, Ilona; Aldridge, Julie; Bernhard, Jurg; Brown, Richard; Ribi, Karin; Psychology; PsychologyCommunication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?, Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, vol.21, 12, 2012,pp 1265-1274
2012Meeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related OutcomesButow, Phyllis; Juraskova, Ilona; Bernhard, Jurg; Brown, Richard; Ribi, Karin; Wilson-Genderson, Maureen; Psychology; PsychologyMeeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related Outcomes, Journal of Clinical Oncology, vol.30, 8, 2012,pp 857-862
2015Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trialsCoates, Alan; Bernhard, Jurg; Burstein, Harold J.; Colleoni, Marco; et al, Various; Luo, Weixiu; Pinotti, Graziella; Puglisi, Fabio; Ribi, Karin; Ruhstaller, Thomas; Spazzapan, Simon; Tondini, Carlo; School of Public Health: Public HealthPatient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials, The Lancet Oncology, vol.16, 7, 2015,pp 848-858
2011Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultationsButow, Phyllis; Juraskova, Ilona; Tattersall, Martin; Bernhard, Jurg; Brown, Richard; Gerber, Daniela; Ribi, Karin; Psychology; Psychology; Central Clinical School: MedicineSharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations, Health expectations : an international journal of public participation in health care and health policy, vol.14, 1, 2011,pp 29-37
2011Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultationsButow, Phyllis; Juraskova, Ilona; Tattersall, Martin; Bernhard, Jurg; Brown, Richard; Gerber, Daniela; Ribi, Karin; Psychology; Psychology; Central Clinical School: MedicineSharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations, Health Expectations, vol.14, 1, 2011,pp 29-37
2012Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerCoates, Alan; Aldridge, Julie; Bernhard, J; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, Olivia; Phillips, Kelly-Anne; Price, Karen N.; Ribi, Karin; Thompson, Alastair; Thurlimann, Beat; School of Public Health: Public HealthSubjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, vol.106, 10, 2012,pp 1618-1625